Skip to main content
Top
Published in: BMC Geriatrics 1/2021

Open Access 01-12-2021 | Dementia | Research article

Short daytime napping reduces the risk of cognitive decline in community-dwelling older adults: a 5-year longitudinal study

Authors: Kaori Kitamura, Yumi Watanabe, Kazutoshi Nakamura, Chikako Takano, Naomi Hayashi, Hisami Sato, Toshiyuki Someya

Published in: BMC Geriatrics | Issue 1/2021

Login to get access

Abstract

Background

Beneficial effects of napping on cognition have been suggested in cross-sectional studies. This study aimed to clarify longitudinal associations between cognitive decline and sleep characteristics, particularly daytime napping, over a 5-year period in older adults.

Methods

Study participants were 389 community-dwelling individuals aged ≥65 years living in Ojiya City, Niigata, Japan. Baseline and follow-up examinations were conducted in 2011–2013 and 2016–2018, respectively. Trained nurses visited and interviewed participants to collect the following information at baseline and follow-up: demographic characteristics, disease history, lifestyle habits including bedtime, sleeping hours, and daytime nap duration, and cognitive function. The assessment of cognitive function was performed using the revised Hasegawa’s dementia scale (HDS-R), with cognitive decline defined as a change in the HDS-R of ≤ − 3 over 5 years. Odds ratios (ORs) for cognitive decline were calculated using multiple logistic regression analysis.

Results

Mean age of participants was 74.6 years (SD 6.4), and the cumulative incidence of cognitive decline was 106/389 (27.3%). The adjusted OR for 1–29 min daytime napping was significantly lower compared to that for no napping (OR = 0.47, 95%CI: 0.23–0.96). Earlier bedtime was associated with cognitive decline (adjusted P for trend = 0.0480).

Conclusion

Short daytime napping (< 30 min) reduces the risk of cognitive decline over 5 years for community-dwelling older people. A future study will be necessary to confirm the effect of short napping on the reduction of risk for clinically diagnosed dementia.
Appendix
Available only for authorised users
Literature
1.
go back to reference International WHOaAsD. Dementia: a public health priority. Geneva: World Health Organization; 2012. International WHOaAsD. Dementia: a public health priority. Geneva: World Health Organization; 2012.
14.
go back to reference Imai YH, K. The revised Hasegawa's dementia scale (HDS-R)-evaluation of its usefulness as a screening test for dementia. Hong Kong J Psychiatry. 1994;4(Suppl 2):20–4. Imai YH, K. The revised Hasegawa's dementia scale (HDS-R)-evaluation of its usefulness as a screening test for dementia. Hong Kong J Psychiatry. 1994;4(Suppl 2):20–4.
15.
go back to reference Jeong JW, Kim KW, Lee DY, Lee SB, Park JH, Choi EA, et al. A normative study of the revised Hasegawa dementia scale: comparison of demographic influences between the revised Hasegawa dementia scale and the Mini-mental status examination. Dement Geriatr Cogn Disord. 2007;24(4):288–93. https://doi.org/10.1159/000107592.CrossRefPubMed Jeong JW, Kim KW, Lee DY, Lee SB, Park JH, Choi EA, et al. A normative study of the revised Hasegawa dementia scale: comparison of demographic influences between the revised Hasegawa dementia scale and the Mini-mental status examination. Dement Geriatr Cogn Disord. 2007;24(4):288–93. https://​doi.​org/​10.​1159/​000107592.CrossRefPubMed
20.
21.
go back to reference Asada T, Motonaga T, Yamagata Z, Uno M, Takahashi K. Associations between retrospectively recalled napping behavior and later development of Alzheimer's disease: association with APOE genotypes. Sleep. 2000;23(5):629–34.PubMed Asada T, Motonaga T, Yamagata Z, Uno M, Takahashi K. Associations between retrospectively recalled napping behavior and later development of Alzheimer's disease: association with APOE genotypes. Sleep. 2000;23(5):629–34.PubMed
28.
Metadata
Title
Short daytime napping reduces the risk of cognitive decline in community-dwelling older adults: a 5-year longitudinal study
Authors
Kaori Kitamura
Yumi Watanabe
Kazutoshi Nakamura
Chikako Takano
Naomi Hayashi
Hisami Sato
Toshiyuki Someya
Publication date
01-12-2021
Publisher
BioMed Central
Keywords
Dementia
Dementia
Published in
BMC Geriatrics / Issue 1/2021
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-021-02418-0

Other articles of this Issue 1/2021

BMC Geriatrics 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.